These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 28415746)
21. JmjC enzyme KDM2A is a regulator of rRNA transcription in response to starvation. Tanaka Y; Okamoto K; Teye K; Umata T; Yamagiwa N; Suto Y; Zhang Y; Tsuneoka M EMBO J; 2010 May; 29(9):1510-22. PubMed ID: 20379134 [TBL] [Abstract][Full Text] [Related]
22. Transcriptional repression of histone deacetylase 3 by the histone demethylase KDM2A is coupled to tumorigenicity of lung cancer cells. Dhar SS; Alam H; Li N; Wagner KW; Chung J; Ahn YW; Lee MG J Biol Chem; 2014 Mar; 289(11):7483-96. PubMed ID: 24482232 [TBL] [Abstract][Full Text] [Related]
23. JMJD3 suppresses stem cell-like characteristics in breast cancer cells by downregulation of Oct4 independently of its demethylase activity. Xun J; Wang D; Shen L; Gong J; Gao R; Du L; Chang A; Song X; Xiang R; Tan X Oncotarget; 2017 Mar; 8(13):21918-21929. PubMed ID: 28423536 [TBL] [Abstract][Full Text] [Related]
24. The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis. Aprelikova O; Chen K; El Touny LH; Brignatz-Guittard C; Han J; Qiu T; Yang HH; Lee MP; Zhu M; Green JE Clin Epigenetics; 2016; 8():38. PubMed ID: 27081402 [TBL] [Abstract][Full Text] [Related]
25. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448. Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489 [TBL] [Abstract][Full Text] [Related]
26. SCF(FBXO22) regulates histone H3 lysine 9 and 36 methylation levels by targeting histone demethylase KDM4A for ubiquitin-mediated proteasomal degradation. Tan MK; Lim HJ; Harper JW Mol Cell Biol; 2011 Sep; 31(18):3687-99. PubMed ID: 21768309 [TBL] [Abstract][Full Text] [Related]
35. KDM2 proteins constrain transcription from CpG island gene promoters independently of their histone demethylase activity. Turberfield AH; Kondo T; Nakayama M; Koseki Y; King HW; Koseki H; Klose RJ Nucleic Acids Res; 2019 Sep; 47(17):9005-9023. PubMed ID: 31363749 [TBL] [Abstract][Full Text] [Related]
36. Dysregulation of ribosome biogenesis and translational capacity is associated with tumor progression of human breast cancer cells. Belin S; Beghin A; Solano-Gonzàlez E; Bezin L; Brunet-Manquat S; Textoris J; Prats AC; Mertani HC; Dumontet C; Diaz JJ PLoS One; 2009 Sep; 4(9):e7147. PubMed ID: 19779612 [TBL] [Abstract][Full Text] [Related]
37. Silencing PRDM14 expression by an innovative RNAi therapy inhibits stemness, tumorigenicity, and metastasis of breast cancer. Taniguchi H; Hoshino D; Moriya C; Zembutsu H; Nishiyama N; Yamamoto H; Kataoka K; Imai K Oncotarget; 2017 Jul; 8(29):46856-46874. PubMed ID: 28423353 [TBL] [Abstract][Full Text] [Related]
38. Regulation of Retinal Development via the Epigenetic Modification of Histone H3. Watanabe S; Murakami A Adv Exp Med Biol; 2016; 854():635-41. PubMed ID: 26427469 [TBL] [Abstract][Full Text] [Related]
39. The epigenetic factor KDM2B regulates cell adhesion, small rho GTPases, actin cytoskeleton and migration in prostate cancer cells. Zacharopoulou N; Tsapara A; Kallergi G; Schmid E; Tsichlis PN; Kampranis SC; Stournaras C Biochim Biophys Acta Mol Cell Res; 2018 Apr; 1865(4):587-597. PubMed ID: 29408056 [TBL] [Abstract][Full Text] [Related]
40. Transcriptional regulation of amino acid metabolism by KDM2B, in the context of ncPRC1.1 and in concert with MYC and ATF4. Chavdoula E; Anastas V; La Ferlita A; Aldana J; Carota G; Spampinato M; Soysal B; Cosentini I; Parashar S; Sircar A; Nigita G; Sehgal L; Freitas MA; Tsichlis PN Metabolism; 2024 Jan; 150():155719. PubMed ID: 37935302 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]